Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Pulmonology
•
Obstructive Lung Disease
•
Asthma
•
Primary Care
What is your approach to inhaler therapy in a patient with asthma who cannot be on an inhaled corticosteroid due to ocular disease?
Answer from: at Academic Institution
I use LABA/LAMA combination.
Sign in or Register to read more
20609
Related Questions
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
When would you recommend prescribing an asthmatic patient budesonide/salbutamol rather than budesonide/formoterol?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
Have you observed adverse mental health side effects in patients who start montelukast?
What is your approach to the work up and evaluation of loss of asthma control while on a biologic such as dupilumab?
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
How do you factor smoking history into biologic selection for asthma since the clinical trials generally excluded these patients?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
What is your approach to de-escalation of asthma inhaler therapy in the setting of negative bronchoprovocation testing when patients are averse to deprescribing?
Is methacholine challenge on its way out?